Atlas Trials

The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans

Clinical trial NCT04126707 · COMPLETED

Trial details

NCT number
NCT04126707
Sponsor
Ascentage Pharma Group Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia (CML)
Start date
2019-11-19
Primary completion
2020-01-13
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.